AI In-Brief
Thailand News in Brief
Thai PBS World
Thailand and the world, every day
AI can make mistakes. Please double-check.
First lot of royally bestowed cancer drugs delivered to NHSO for universal healthcare scheme patients
13 Sept 19:14 Key points summarised by AI
- The Chulabhorn Royal Academy (CRA) delivered the first batch of Imcranib 100, a royally bestowed targeted cancer drug, to the National Health Security Office (NHSO), ensuring nationwide access for Universal Coverage Scheme patients.
- Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana graciously donated 690,000 tablets of Imcranib 100, initiating its distribution through the Government Pharmaceutical Organisation (GPO) to ensure equitable access across the country.
- Imcranib 100 is Thailand's first domestically formulated and manufactured targeted cancer drug, produced in a PIC/S GMDP certified facility, significantly bolstering national pharmaceutical security and reducing reliance on imported medicines.
- This advanced medication effectively inhibits cancer cell proliferation and metastasis with high efficiency and significantly fewer side effects than conventional chemotherapy, treating various malignancies including Chronic Myeloid Leukaemia (CML) and Gastrointestinal Stromal Tumours (GIST).
- The rollout marks a significant upgrade to Thailand's public healthcare system, reflecting a royal determination to dismantle financial barriers and extend equal opportunities for state-of-the-art medical care to all citizens.
